Empirical estimates of the lead time distribution for prostate cancer based on two independent representative cohorts of men not subject to prostate-specific antigen screening Academic Article uri icon

Overview

MeSH Major

  • Mass Screening
  • Models, Theoretical
  • Prostate-Specific Antigen
  • Prostatic Neoplasms

abstract

  • The distinct differences between the observed distribution of lead times and those used in modeling studies illustrate the need to model overdiagnosis rates using empirical data.

publication date

  • May 2010

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC2866147

Digital Object Identifier (DOI)

  • 10.1158/1055-9965.EPI-09-1251

PubMed ID

  • 20406957

Additional Document Info

start page

  • 1201

end page

  • 7

volume

  • 19

number

  • 5